Flagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at cellular level with disease by Nanoseq, a sequencing method licenced from the Wellcome Sanger Institute.
Finnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant.
https://european-biotechnology.com/wp-content/uploads/2024/04/solar-foods2.jpg7681024Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-21 09:36:402024-07-09 12:38:23Solar Foods raises €8m in Series B financing
https://european-biotechnology.com/wp-content/uploads/2024/04/Microharvest2-scaled.jpg17072560Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-20 08:52:592024-07-09 13:19:33Germany boosts protein transition with €38m
German precision fermentation specialist MicroHarvest GmbH has launched a single-cell protein pilot plant in Lison with an initial capacity of 25kg per day.
The biotech company Cellaïon, based in the Walloon biotechnology valley in Mont-St-Guibert, Belgium, has appointed a new CEO: Dr James Neil Phillips has taken on the role, succeeding Cellaïon’s founder Etienne Sokal.
https://european-biotechnology.com/wp-content/uploads/2024/04/EBcom_James_Neill_Phillips.jpg472420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-11-16 10:00:002024-05-24 14:30:36New CEO for Cellaïon
Due to the global niche character of pharmaceutical biotechnology, research collaborations and market entries on an international level are essential. Agility and market knowledge are required to maintain an overview in a rapidly evolving environment and to initiate a sustainable internationalisation process.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB323_ae_cs_BioRN_kl.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-15 11:10:002024-06-13 11:15:05Paving the way to internationalisation
The Innovative Medicine Initiative 2 JU-funded €25m project COMBINE is joining forces with CARB-X & CAIRD, iiCON and Pharmacology Discovery Services to improve in vivo antibiotics testing.
https://european-biotechnology.com/wp-content/uploads/2024/04/ANDERS_KARLEN.jpg467700Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-15 06:36:002024-07-09 13:38:49AMR: Partnership set to improve in vivo antibiotics testing
Dutch VectorY Tx BV has closed one of this yerss largest Series A financing rounds in Europe at €129m to push its vecorised antibody pipeline in CNS proteinopathies.
https://european-biotechnology.com/wp-content/uploads/2024/04/VTx_pipeline.png392956Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-13 20:37:192024-07-09 13:40:43VectorY Therapeutics raises €129m in Series A round
Novo Nordisk invests €2.1bn in production expansion
Latest NewsIn the race for global market share of its obesity and diabetes blockbuster semaglutide, Novo Nordisk is expanding production in Europe.
Quotient Therapeutics kicks-off with US$50m financing
Latest NewsFlagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at cellular level with disease by Nanoseq, a sequencing method licenced from the Wellcome Sanger Institute.
Enhance3D Genomics expands leadership team
AppointmentsCambridge-based Enhanc3D Genomics announced the appointment of Hazel Jones as Chief Operating Officer at beginning of November.
Solar Foods raises €8m in Series B financing
Latest NewsFinnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant.
Germany boosts protein transition with €38m
Latest NewsThe Budget Committee of the German Bundestag has announced to channel €38m in funding into the sustainable protein transition next year.
Microharvest GmbH launches SCP-Pilot plant in Lissabon
Latest NewsGerman precision fermentation specialist MicroHarvest GmbH has launched a single-cell protein pilot plant in Lison with an initial capacity of 25kg per day.
New CEO for Cellaïon
AppointmentsThe biotech company Cellaïon, based in the Walloon biotechnology valley in Mont-St-Guibert, Belgium, has appointed a new CEO: Dr James Neil Phillips has taken on the role, succeeding Cellaïon’s founder Etienne Sokal.
Paving the way to internationalisation
BackgroundDue to the global niche character of pharmaceutical biotechnology, research collaborations and market entries on an international level are essential. Agility and market knowledge are required to maintain an overview in a rapidly evolving environment and to initiate a sustainable internationalisation process.
AMR: Partnership set to improve in vivo antibiotics testing
Latest NewsThe Innovative Medicine Initiative 2 JU-funded €25m project COMBINE is joining forces with CARB-X & CAIRD, iiCON and Pharmacology Discovery Services to improve in vivo antibiotics testing.
VectorY Therapeutics raises €129m in Series A round
Latest NewsDutch VectorY Tx BV has closed one of this yerss largest Series A financing rounds in Europe at €129m to push its vecorised antibody pipeline in CNS proteinopathies.